Specialty Pharmacy

VALLEY FORGE, Pa. — AmerisourceBergen on Thursday reported its third quarter results, posting a 4.9% increase in revenue, which hit $38.7 billion. The company’s gross profit declined 2.5% to $1.1 billion, which it attributed to a $121 million decrease in gains from antitrust litigation settlements and a decrease in the pharmaceutical distribution services segment.

FLINT, Mich. — Diplomat Pharmacy will be exclusively dispensing Cycle Pharmaceuticals’ Nityr (nitisinone) tablets, the company announced Thursday. The Food and Drug Administration approved Nityr on Aug. 1 to treat the rare disease hereditary tyrosinemia Type 1, or HT-1, in combination with dietary restriction of tyrosine and phenylalanine.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug to treat adults with chronic hepatitis C virus genotypes 1-6. Mavyret, from AbbVie, was approved for HCV patients without cirrhosis or with mild cirrhosis, including patients with moderate to severe kidney disease and those on dialysis.

The FDA said that Mavyret is the first treatment of eight-week duration for all hepatitis C genotypes.

DEERFIELD, Ill. — Walgreens Boots Alliance has had a busy week.

As a minority investor, the company on Wednesday announced that it had formed a new company with KKR, through which the two acquired institutional pharmacy company PharMerica. The all-cash transaction is valued at roughly $1.4 billion and will make PharMerica a private company.

SILVER SPRING, Md. — The Food and Drug Administration on Tuesday approved a new indication for Vertex Pharmaceuticals’ Kalydeco (ivacaftor). The new indication is for use in more than 600 people with cystic fibrosis ages 2 years and older who have one of five residual function mutations.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new, targeted treatment for patients with relapsed/refractory acute myeloid leukemia. Idhifa (enasidenib), from Celgene, was approved for use with the RealTime IDH2 Assay, used to detect specific mutations in the IDH2 gene in patients with acute myeloid leukemia.

FLINT, Mich. — Diplomat Pharmacy was among the fastest-growing southeast Michigan companies identified this year by Crain’s Detroit Business. The magazine’s annual Fast 50 list ranks companies based on three-year revenue growth.

DENVER — The first methotrexate oral solution approved by the Food and Drug Administration, Xatmep, is now available, manufacturer Silvergate Pharmaceuticals announced Monday. The drug, approved by the FDA in April, is indicated to treat acute lymphoblastic leukemia and manage polyarticular juvenile idiopathic arthritis in pediatric patients.